Cigna Investments’s Silicon Laboratories SLAB Stock Holding History

Cigna Investments’s Portfolio SLAB Stock Details SLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,376	Closed	-$210K	–	763
2021 Q2	$210K	Sell	1,376 -200	-13%	-$28K	0.02%	706
2021 Q1	$222K	Buy	+1,576	New	+$226K	0.02%	700
2020 Q3	–	Sell	-4,977	Closed	-$499K	–	748
2020 Q2	$499K	Buy	+4,977	New	+$465K	0.05%	386

Other funds holding SLAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cigna Investments's SLAB Position: Q3 2021 in Review

Cigna Investments sold out of Silicon Laboratories (SLAB) in Q3 2021, closing a stake of 1,376 shares — an estimated $210K sold.

Cigna Investments first reported a position in SLAB in Q2 2020 and held it in 3 quarters. The position peaked at $499K in Q2 2020. 278 funds tracked by Wall St. Rank hold SLAB as of Q3 2021.

Cigna Investments reported no remaining Silicon Laboratories position as of Q3 2021 after selling out during the quarter.
Cigna Investments sold 1,376 Silicon Laboratories shares in Q3 2021, an estimated $210K.
Cigna Investments first reported a position in Silicon Laboratories in Q2 2020 and held it in 3 quarters.
Cigna Investments's Silicon Laboratories position peaked at $499K in Q2 2020.
278 funds tracked by Wall St. Rank held Silicon Laboratories as of Q3 2021.

Based on Cigna Investments's 13F filing for Q3 2021, filed 12 Nov 2021.